University of Groningen. Vasoregression in incipient diabetic retinopathy Pfister, Frederick

Transcription

1 University of Groningen Vasoregression in incipient diabetic retinopathy Pfister, Frederick IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2011 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Pfister, F. (2011). Vasoregression in incipient diabetic retinopathy: Angiopoietin-2 dependency and the effect of Erythropoietin and Carnosine treatment Groningen: s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date:

2 APPENDICES References Curriculum Vitae List of publications Acknowledgement 197

3 References 1.! Wild, S., et al., Global prevalence of diabetes: estimates for the year 2000 and projections for Diabetes Care, (5): p ! Ritz, E., et al., End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis, (5): p ! Resnikoff, S., et al., Global data on visual impairment in the year Bull World Health Organ, (11): p ! Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia, (3): p ! Fong, D.S., et al., Diabetic retinopathy. Diabetes Care, (10): p ! Malone, J.I., et al., Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care, (3): p ! Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet, (9131): p ! Klein, R., et al., The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology, (12): p ! Klein, R., et al., The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol, (4): p ! Klein, R., et al., Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol, (11): p ! Garner, A., Histopathology of diabetic retinopathy in man. Eye (Lond), ( Pt 2): p ! Cogan, D.G. and T. Kuwabara, The mural cell in perspective. Arch Ophthalmol, (2): p ! Cogan, D.G., D. Toussaint, and T. Kuwabara, Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol, : p ! Kuwabara, T. and D.G. Cogan, Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol, : p ! Hughes, S., et al., Altered pericyte-endothelial relations in the rat retina during aging: implications for vessel stability. Neurobiol Aging, (12): p ! Robison, W.G., Jr., et al., Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats. Curr Eye Res, (4): p ! Barber, A.J., et al., The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci, (6): p ! Midena, E., et al., Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res, (2): p ! Hammes, H.P., et al., The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia, (2): p ! Engerman, R.L. and J.W. Kramer, Dogs with induced or spontaneous diabetes as models for the study of human diabetes mellitus. Diabetes, (Suppl 1 Pt 2): p ! Gardiner, T.A., et al., Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol, (1): p

4 22.! Kim, S.Y., et al., Retinopathy in monkeys with spontaneous type 2 diabetes. Invest Ophthalmol Vis Sci, (12): p ! Benjamin, L.E., I. Hemo, and E. Keshet, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development, (9): p ! Orlidge, A. and P.A. D'Amore, Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol, (3): p ! Korff, T., et al., Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J, (2): p ! Sundberg, C., et al., Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest, (4): p ! Hellstrom, M., et al., Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol, (3): p ! Hammes, H.P., et al., Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes, (4): p ! Hammes, H.P., et al., Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia, (3): p ! Hoffmann, J., et al., Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost, (4): p ! Lin, J., et al., Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia, (5): p ! Kuwabara, T. and D.G. Cogan, Retinal vascular patterns. VII. Acellular change. Invest Ophthalmol, (6): p ! Kuwabara, T., J.M. Carroll, and D.G. Cogan, Retinal vascular patterns. III. Age, hypertension, absolute glaucoma, injury. Arch Ophthalmol, : p ! Ashton, N., Pathogenesis of diabetic retinopathy, in Diabetic Retinopathy, J.R. Little HL, Patz AP, Forsham PH, Editor. 1983, Thieme-Stratton Inc: New York. p ! Roy, S., et al., Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes, (5): p ! Roy, S., M. Maiello, and M. Lorenzi, Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest, (1): p ! Roy, S. and T. Sato, Role of vascular basement membrane components in diabetic microangiopathy. Drug News Perspect, (2): p ! Cagliero, E., et al., Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest, (2): p ! Cagliero, E., et al., Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes, (1): p ! Nishikawa, T., et al., Changes in diabetic retinal matrix protein mrna levels in a common transgenic mouse strain. Curr Eye Res, (1): p ! Oshitari, T., et al., Effect of combined antisense oligonucleotides against highglucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes, (1): p ! Oshitari, T., D. Brown, and S. Roy, SiRNA strategy against overexpression of extracellular matrix in diabetic retinopathy. Exp Eye Res, (1): p

5 43.! Barber, A.J., A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry, (2): p ! Bresnick, G.H., Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol, (7): p ! Mizutani, M., C. Gerhardinger, and M. Lorenzi, Muller cell changes in human diabetic retinopathy. Diabetes, (3): p ! Lieth, E., et al., Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes, (5): p ! Rungger-Brandle, E., A.A. Dosso, and P.M. Leuenberger, Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci, (7): p ! Zhang, L., et al., Retrograde axonal transport impairment of large- and mediumsized retinal ganglion cells in diabetic rat. Curr Eye Res, (2): p ! Ghirlanda, G., et al., Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes, (9): p ! Holopigian, K., et al., Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci, (11): p ! King, G.L. and M. Brownlee, The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am, (2): p ! Zhu, S.Q., et al., Structure-function relationships of insulin receptor interactions in cultured mouse astrocytes. Brain Res, (1-2): p ! Aizenman, Y. and J. de Vellis, Synergistic action of thyroid hormone, insulin and hydrocortisone on astrocyte differentiation. Brain Res, (2): p ! Hammes, H.P., H.J. Federoff, and M. Brownlee, Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med, (5): p ! Brownlee, M., The pathobiology of diabetic complications: a unifying mechanism. Diabetes, (6): p ! Kowluru, R.A. and S.N. Abbas, Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci, (12): p ! Du, Y., C.M. Miller, and T.S. Kern, Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med, (11): p ! Ellis, E.A., et al., Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med, (1): p ! Ford, E.S., et al., The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes, (9): p ! Kowluru, R.A., J. Tang, and T.S. Kern, Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes, (8): p ! Haskins, K., et al., Oxidative stress in type 1 diabetes. Ann N Y Acad Sci, : p ! Engerman, R.L. and T.S. Kern, Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes, (6): p ! A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group. Arch Ophthalmol, (9): p ! Asnaghi, V., et al., A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes, (2): p

6 65.! Sun, W., et al., A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes, (10): p ! Teo, C.F., E.E. Wollaston-Hayden, and L. Wells, Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol, (1-2): p ! Degrell, P., et al., Evidence of O-linked N-acetylglucosamine in diabetic nephropathy. Life Sci, (13-14): p ! Hammes, H.P., et al., Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med, (3): p ! Sayeski, P.P. and J.E. Kudlow, Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem, (25): p ! Kolm-Litty, V., et al., High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest, (1): p ! Du, X.L., et al., Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A, (22): p ! Yao, D., et al., High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of msin3a. J Biol Chem, (42): p ! Yamagishi, S., et al., Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun, (2): p ! Stitt, A.W., et al., Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol, (2): p ! Xu, X., et al., Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol, (1): p ! Li, Y.M., et al., Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A, (20): p ! Abordo, E.A. and P.J. Thornalley, Synthesis and secretion of tumour necrosis factoralpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol Lett, (3): p ! Doi, T., et al., Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via plateletderived growth factor. Proc Natl Acad Sci U S A, (7): p ! Kirstein, M., et al., Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest, (2): p ! Schmidt, A.M., et al., Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest, (3): p

7 81.! Skolnik, E.Y., et al., Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med, (4): p ! Huang, Q. and Y. Yuan, Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol, (5 Pt 2): p. H ! Koya, D. and G.L. King, Protein kinase C activation and the development of diabetic complications. Diabetes, (6): p ! Nishizuka, Y., Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, (5082): p ! Park, J.Y., et al., Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes, (7): p ! Pomero, F., et al., Effects of protein kinase C inhibition and activation on proliferation and apoptosis of bovine retinal pericytes. Diabetologia, (3): p ! Xia, P., et al., Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest, (9): p ! Amadio, M., et al., PKCbetaII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression. Pharmacol Res, (1): p ! Aiello, L.P., et al., Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective betaisoform-selective inhibitor. Diabetes, (9): p ! Geraldes, P., et al., Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med, (11): p ! Ishii, H., et al., Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science, (5262): p ! Kowluru, R.A., et al., Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases. Diabetes, (3): p ! Danis, R.P., et al., Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY Invest Ophthalmol Vis Sci, (1): p ! Cotter, M.A., A.M. Jack, and N.E. Cameron, Effects of the protein kinase C beta inhibitor LY on neural and vascular function in rats with streptozotocininduced diabetes. Clin Sci (Lond), (3): p ! The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial. Diabetes, (7): p ! Aiello, L.P., et al., Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology, (12): p ! Li, W., et al., Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Chin Med J (Engl), (9): p ! Barber, A.J., et al., Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest, (4): p ! Podesta, F., et al., Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol, (3): p

8 100.! Kowluru, R.A. and P. Koppolu, Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res, (9): p ! Mohr, S., et al., Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes, (4): p ! Romeo, G., et al., Activation of nuclear factor-kappab induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes, (7): p ! Joussen, A.M., et al., Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocininduced diabetes. FASEB J, (1): p ! Park, S.H., et al., Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia, (9): p ! Abu-El-Asrar, A.M., et al., Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci, (8): p ! Kowluru, R.A., S. Chakrabarti, and S. Chen, Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NFkappaB) in the retina. Acta Diabetol, (4): p ! Lecomte, M., et al., Involvement of caspase-10 in advanced glycation end-productinduced apoptosis of bovine retinal pericytes in culture. Biochim Biophys Acta, (3): p ! Martin, P.M., et al., Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci, (9): p ! Kowluru, R.A., Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal, (11-12): p ! Nakanishi, Y., et al., Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase. Exp Eye Res, (5): p ! Yatoh, S., et al., Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev, (1): p ! Behl, Y., et al., Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol, (5): p ! Behl, Y., et al., FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes, (4): p ! Diffley, J.M., et al., Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways. Mol Vis, : p ! Khalfaoui, T., N. Basora, and A. Ouertani-Meddeb, Apoptotic factors (Bcl-2 and Bax) and diabetic retinopathy in type 2 diabetes. J Mol Histol, (2-3): p ! Mizutani, M., T.S. Kern, and M. Lorenzi, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest, (12): p ! Kowluru, R.A. and S. Odenbach, Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes, (12): p ! Alikhani, M., S. Roy, and D.T. Graves, FOXO1 plays an essential role in apoptosis of retinal pericytes. Mol Vis, : p ! Han, J.H., et al., High glucose-induced apoptosis in bovine retinal pericytes is associated with transforming growth factor beta and betaig-h3: betaig-h3 induces 203

9 apoptosis in retinal pericytes by releasing Arg-Gly-Asp peptides. Clin Experiment Ophthalmol, (6): p ! Lindblom, P., et al., Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev, (15): p ! Enge, M., et al., Endothelium-specific platelet-derived growth factor-b ablation mimics diabetic retinopathy. EMBO J, (16): p ! Hammes, H.P., Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res, Suppl 1: p ! Uemura, A., et al., Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest, (11): p ! Hellstrom, M., et al., Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development, (14): p ! Lindahl, P., et al., Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, (5323): p ! Wakui, S., et al., Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest, (11): p ! Maisonpierre, P.C., et al., Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, (5322): p ! Fiedler, U., et al., Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med, (2): p ! Suri, C., et al., Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, (7): p ! Thurston, G., et al., Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med, (4): p ! Augustin, H.G., et al., Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat Rev Mol Cell Biol, (3): p ! Joussen, A.M., et al., Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol, (5): p ! Asahara, T., et al., Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res, (3): p ! DeBusk, L.M., D.E. Hallahan, and P.C. Lin, Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res, (1): p ! Hackett, S.F., et al., Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol, (3): p ! Hayes, A.J., et al., Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res, (3): p ! Hori, S., et al., A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J Neurochem, (2): p ! Yuan, H.T., S.P. Yang, and A.S. Woolf, Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells. Kidney Int, (5): p ! Krikun, G., et al., Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun, (1): p

10 140.! Ohashi, H., et al., Alterations in expression of angiopoietins and the Tie-2 receptor in the retina of streptozotocin induced diabetic rats. Mol Vis, : p ! Scharpfenecker, M., et al., The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci, (Pt 4): p ! Oshima, Y., et al., Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor. J Cell Physiol, (3): p ! Oshima, Y., et al., Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive. FASEB J, (8): p ! Hanahan, D., Signaling vascular morphogenesis and maintenance. Science, (5322): p ! Fiedler, U., et al., The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood, (11): p ! Kahn, H.A. and R. Hiller, Blindness caused by diabetic retinopathy. Am J Ophthalmol, (1): p ! Moss, S.E., R. Klein, and B.E. Klein, Ten-year incidence of visual loss in a diabetic population. Ophthalmology, (6): p ! Thylefors, B., et al., Global data on blindness. Bull World Health Organ, (1): p ! Smith, L.E., et al., Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci, (1): p ! Pierce, E.A., et al., Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A, (3): p ! Miller, J.W., A.P. Adamis, and L.P. Aiello, Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev, (1): p ! Shweiki, D., et al., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, (6398): p ! Levy, A.P., et al., Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem, (22): p ! Aiello, L.P., et al., Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol, (12): p ! Aiello, L.P., et al., Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A, (23): p ! Ozaki, H., et al., Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol, (2): p ! Lobov, I.B., P.C. Brooks, and R.A. Lang, Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A, (17): p ! Sato, T.N., et al., Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, (6535): p ! Thurston, G., et al., Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science, (5449): p ! Takagi, H., et al., Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci, (1): p ! Pichiule, P., J.C. Chavez, and J.C. LaManna, Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem, (13): p

11 162.! Hackett, S.F., et al., Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol, (2): p ! Park, Y.S., N.H. Kim, and I. Jo, Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mrna in bovine retinal pericytes. Microvasc Res, (2): p ! Holash, J., S.J. Wiegand, and G.D. Yancopoulos, New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene, (38): p ! Carmeliet, P., Angiogenesis in health and disease. Nat Med, (6): p ! Jain, R.K., Molecular regulation of vessel maturation. Nat Med, (6): p ! Gale, N.W., et al., Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell, (3): p ! Oh, H., et al., Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem, (22): p ! Tidhar, A., et al., A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells. Dev Dyn, (1): p ! Hammes, H.P., et al., Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med, (5): p ! Gardiner, T.A., et al., Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol, (2): p ! Gerhardt, H., et al., VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol, (6): p ! Das, A., et al., Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Lab Invest, (11): p ! Daly, C., et al., Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev, (9): p ! Potente, M., et al., Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest, (9): p ! Furuyama, T., et al., Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem, (33): p ! Armulik, A., A. Abramsson, and C. Betsholtz, Endothelial/pericyte interactions. Circ Res, (6): p ! Iivanainen, E., et al., Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor. FASEB J, (12): p ! Hammes, H.P., et al., Pericytes and the pathogenesis of diabetic retinopathy. Diabetes, (10): p ! Hoffmann, J., et al., Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J, (14): p ! Kim, I., et al., Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Oncogene, (39): p ! Glatt, H.J. and P. Henkind, Aging changes in the retinal capillary bed of the rat. Microvasc Res, (1): p

12 183.! Allt, G. and J.G. Lawrenson, Pericytes: cell biology and pathology. Cells Tissues Organs, (1): p ! Feng, Y., et al., Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost, (1): p ! Roviezzo, F., et al., Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther, (2): p ! Kang, D.H., et al., Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis, (3): p ! Wagatsuma, A., Effect of aging on expression of angiogenesis-related factors in mouse skeletal muscle. Exp Gerontol, (1): p ! Baffert, F., et al., Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res, (7): p ! Ochs, M., T.M. Mayhew, and W. Knabe, To what extent are the retinal capillaries ensheathed by Muller cells? A stereological study in the tree shrew Tupaia belangeri. J Anat, ( Pt 3): p ! Watanabe, D., et al., Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol, (3): p ! Chi, J.T., et al., Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A, (19): p ! Matsumara, T., Hyperglycemia increases angiopoietin-2 expression in retinal Muller cells through superoxide-induced overproduction of a-oxoaldehyde age precursors. Diabetes, ! Yao, D., et al., Methylglyoxal modification of msin3a links glycolysis to angiopoietin-2 transcription. Cell, (3): p ! Pfister, F., et al., Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes, (9): p ! Sims, D.E., Diversity within pericytes. Clin Exp Pharmacol Physiol, (10): p ! Sims, D.E., Recent advances in pericyte biology--implications for health and disease. Can J Cardiol, (10): p ! DeRuiter, M.C., et al., Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. Circ Res, (4): p ! Etchevers, H.C., et al., The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development, (7): p ! Rajantie, I., et al., Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood, (7): p ! Sundberg, C., et al., Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest, (2): p ! Thomas, W.E., Brain macrophages: on the role of pericytes and perivascular cells. Brain Res Brain Res Rev, (1): p ! Bergers, G. and S. Song, The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol, (4): p ! Peppiatt, C.M., et al., Bidirectional control of CNS capillary diameter by pericytes. Nature, (7112): p

13 204.! Joyce, N.C., M.F. Haire, and G.E. Palade, Contractile proteins in pericytes. I. Immunoperoxidase localization of tropomyosin. J Cell Biol, (5): p ! Joyce, N.C., M.F. Haire, and G.E. Palade, Contractile proteins in pericytes. II. Immunocytochemical evidence for the presence of two isomyosins in graded concentrations. J Cell Biol, (5): p ! Nehls, V. and D. Drenckhahn, Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol, (1): p ! Bauer, H.C., M. Steiner, and H. Bauer, Embryonic development of the CNS microvasculature in the mouse: new insights into the structural mechanisms of early angiogenesis. EXS, : p ! Betsholtz, C., Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev, (4): p ! Egginton, S., et al., The role of pericytes in controlling angiogenesis in vivo. Adv Exp Med Biol, : p ! Gerhardt, H. and C. Betsholtz, Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res, (1): p ! Ozerdem, U. and W.B. Stallcup, Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis, (3): p ! Antonelli-Orlidge, A., S.R. Smith, and P.A. D'Amore, Influence of pericytes on capillary endothelial cell growth. Am Rev Respir Dis, (4): p ! Hughes, S. and T. Chan-Ling, Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci, (8): p ! Bondjers, C., et al., Transcription profiling of platelet-derived growth factor-bdeficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol, (3): p ! Cho, H., et al., Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J, (3): p ! Ozerdem, U., E. Monosov, and W.B. Stallcup, NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res, (1): p ! vom Hagen, F., et al., Early loss of arteriolar smooth muscle cells: more than just a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes, (10): p ! Uhlmann, K., et al., Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes, (6): p ! Dore-Duffy, P., et al., Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res, (1): p ! Gonul, E., et al., Early pericyte response to brain hypoxia in cats: an ultrastructural study. Microvasc Res, (1): p ! Baffert, F., et al., Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol, (2): p. H ! Chen, B.H., D.Y. Jiang, and L.S. Tang, Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci, (11): p ! Kim, J., et al., Methylglyoxal induces apoptosis mediated by reactive oxygen species in bovine retinal pericytes. J Korean Med Sci, (1): p ! Yang, R., et al., Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy. Ann N Y Acad Sci, : p

14 225.! Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature, (6865): p ! Bierhaus, A. and P.P. Nawroth, Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia, (11): p ! Coughlan, M.T., et al., RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol, (4): p ! Obrosova, I.G., et al., Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocindiabetic rats. Diabetes, (3): p ! Karachalias, N., et al., Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans, (Pt 6): p ! Januszewski, A.S., et al., Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans, (Pt 6): p ! Friess, U., et al., Liquid chromatography-based determination of urinary free and total N(epsilon)-(carboxymethyl)lysine excretion in normal and diabetic subjects. J Chromatogr B Analyt Technol Biomed Life Sci, (2): p ! Zheng, L. and T.S. Kern, Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci, : p ! Pacher, P., et al., Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem, (3): p ! Hammes, H.P., et al., Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia, (6): p ! Song, J.H. and T. Miyazawa, Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil. Atherosclerosis, (1): p ! Lieberthal, W. and J.S. Levine, The role of the mammalian target of rapamycin (mtor) in renal disease. J Am Soc Nephrol, (12): p ! Frank, R.N., Diabetic retinopathy. N Engl J Med, (1): p ! Aiello, L.P., et al., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med, (22): p ! Watanabe, D., et al., Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med, (8): p ! Spinowitz, B.S. and R.D. Pratt, Epoetin delta is effective for the management of anaemia associated with chronic kidney disease. Curr Med Res Opin, (12): p ! Watanabe, D., [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy]. Nippon Ganka Gakkai Zasshi, (11): p ! Rabie, T. and H.H. Marti, Brain protection by erythropoietin: a manifold task. Physiology (Bethesda), : p ! Brines, M., et al., Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A, (41): p ! Chong, Z.Z., J.Q. Kang, and K. Maiese, Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation, (23): p

15 245.! Zhang, J., et al., Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci, (2): p ! Brines, M. and A. Cerami, Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci, (6): p ! Brines, M. and A. Cerami, Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int, (2): p ! Rezaeian, F., et al., Erythropoietin protects critically perfused flap tissue. Ann Surg, (6): p ! Liu, B., et al., Effect of dicarbonyl modification of fibronectin on retinal capillary pericytes. Invest Ophthalmol Vis Sci, (6): p ! Villa, P., et al., Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab, (3): p ! Bahlmann, F.H., et al., Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation, (8): p ! Hammes, H.P., et al., Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia, (6): p ! Shinohara, M., et al., Overexpression of glyoxalase-i in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest, (5): p ! Chiu, J., et al., Oxidative stress-induced, poly(adp-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Can J Physiol Pharmacol, (6): p ! Toba, H., et al., Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur J Pharmacol, (1-3): p ! Obrosova, I.G., et al., Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia, (10): p ! Genc, S., et al., Erythropoietin restores glutathione peroxidase activity in 1- methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett, (1-2): p ! Koistinaho, J., et al., Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes and microglia following transient focal brain ischaemia in the rat. Eur J Neurosci, (11): p ! Schmeer, C., et al., Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo. Invest Ophthalmol Vis Sci, (11): p ! Chen, J., et al., Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest, (2): p ! Adamis, A.P., et al., Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol, (1): p ! Chibber, R., et al., Leukocytes in diabetic retinopathy. Curr Diabetes Rev, (1): p ! Joussen, A.M., et al., A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J, (12): p

16 264.! McLeod, D.S., et al., Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol, (3): p ! Gastinger, M.J., R.S. Singh, and A.J. Barber, Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci, (7): p ! Gerber, H.P., V. Dixit, and N. Ferrara, Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem, (21): p ! Nishijima, K., et al., Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol, (1): p ! Sondell, M., G. Lundborg, and M. Kanje, Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res, (2): p ! Falk, T., S. Zhang, and S.J. Sherman, Vascular endothelial growth factor B (VEGF- B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol Neurodegener, : p ! Spuch, C., et al., The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials, (21): p ! Hochhauser, E., et al., Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. Apoptosis, (1): p ! Wakida, K., et al., Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience, (1): p ! Wang, Q., et al., Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina. Diabetologia, (6): p ! Lipsic, E., et al., Timing of erythropoietin treatment for cardioprotection in ischemia/ reperfusion. J Cardiovasc Pharmacol, (4): p ! Sharples, E.J., et al., Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol, (8): p ! Wu, H., et al., Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg, (6): p ! Guneli, E., et al., Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol Med, (9-10): p ! Nowicki, M., Erythropoietin and hypertension. J Hum Hypertens, (2): p ! Lemmer, B., et al., Circadian blood pressure variation in transgenic hypertensive rats. Hypertension, (1): p ! Hammes, H.P., et al., Upregulation of the vascular endothelial growth factor/ vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes, (3): p ! Steinle, J.J., et al., Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice. Exp Eye Res, (6): p ! Swift, S., et al., Absence of functional EpoR expression in human tumor cell lines. Blood, (21): p